STERIS plc (STE)
What changed in recent filings
- Institutions — 3 new · 1 added · 1 reduced13F · as of end of 2026 Q2
- Risk factors — 1 added · 4 removed · new: Our investments in our business and product…10-K Mar 31, 2025 → Mar 31, 2026 · filed 3 months ago
What changed in recent SEC filings — factual, not a buy/sell recommendation.
Institutions holding STERIS plc
How many of the institutions we track reported holding this stock, quarter by quarter.
2019 Q1: 1 → 2026 Q2: 5 institutions
Counts the 52 institutions we track that reported holding this stock — their full reported holdings, not just the largest positions. Not the total number of institutional holders in the US. Figures are as of quarter-end and disclosed up to 45 days later. Descriptive only — not investment advice.
Which institutions hold STERIS plc
Institutions we track that reported holding this stock in their most recent 13F.
- Bridgewater Associates0.01% of portfolio · since 2020 Q3
- Tudor Investment Corp0.03% of portfolio · since 2025 Q2
- National Pension Service (Korea)under 0.01% of portfolio · held as of 2026 Q2 or earlier
- Generation Investment Management4.67% of portfolio · held as of 2026 Q2 or earlier
- Blackstoneunder 0.01% of portfolio · held as of 2026 Q2 or earlier
Based on 13F filings — quarter-end holdings, disclosed up to 45 days later. Holding a stock is a fact we report, not a recommendation to buy or sell.
Company overview
Steris is an Ireland-domiciled medical technology company focused on sterilization services and infection prevention. The company is the global leader in contract sterilization services, ensuring the safe delivery of single-use and implantable medical equipment to hospitals around the world. Steris also sells sterilizers, washer-disinfectors, and other decontamination equipment and supplies for use by care provider facilities and in biopharma manufacturing sites. Domiciled in the United States before its inversion to Ireland, the firm derives approximately 70% of its revenue from Healthcare Services, 20% from Applied Sterilization Technologies, or AST, and 10% from life sciences services after the divestment of its dental products business.
What is the Biotech & Health sector?
Pharma, biotech, and medical devices. Driven by trial-result events.
STERIS plc is classified under the Biotech & Health sector. See peers below.
ETFs holding STERIS plc
Per SEC N-PORT · 2026-06-30 · by weight · factual
STE on Stocklore
- Revenue by segment — segment weights verified from SEC filings, YoY changes, growth drivers and concentration
- Financials & earnings quality — 6 metrics (FCF conversion, ROIC, net debt, etc.) to gauge profit quality
- 13F institutional holdings — holdings and weight changes of major institutions (45-day delay)
- Sector-relative metrics — Valuation and growth compared with the Biotech & Health average
Peers · Biotech & Health
STE FAQ
What is STERIS plc (STE)?
Steris is an Ireland-domiciled medical technology company focused on sterilization services and infection prevention. The company is the global leader in contract sterilization services, ensuring the safe delivery of single-use and implantable medical equipment to hospitals around the world. Steris also sells sterilizers, washer-disinfectors, and other decontamination equipment and supplies for use by care provider facilities and in biopharma manufacturing sites. Domiciled in the United States before its inversion to Ireland, the firm derives approximately 70% of its revenue from Healthcare Services, 20% from Applied Sterilization Technologies, or AST, and 10% from life sciences services after the divestment of its dental products business.
What sector is STERIS plc in?
STERIS plc is classified under Biotech & Health. Pharma, biotech, and medical devices. Driven by trial-result events.
Where can I analyze STERIS plc (STE) stock?
On Stocklore you can see STE's financials & earnings quality, 13F institutional holdings, and sector-relative metrics in one place. This page is for information and tools — not a buy/sell recommendation.
Data sources: SEC EDGAR (financials & filings), 13F (institutional holdings, as of quarter-end), market data. This page is for information and analysis tools — it does not recommend buying or selling any security. Investment decisions and responsibility are your own.